| Name | Pomotrelvir |
|---|
| Description | Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activity and can be used in the research of novel coronavirus (COVID-19)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H26ClN5O3 |
|---|---|
| Molecular Weight | 455.94 |